Cart
sales@molnova.com
m-PEG7-4-nitrophenyl carbonate
CAS No. 678150-56-6
m-PEG7-4-nitrophenyl carbonate ( —— )
Catalog No. M24690 CAS No. 678150-56-6
m-PEG7-4-nitrophenyl carbonate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 83 | In Stock |
|
| 5MG | 125 | In Stock |
|
| 10MG | 185 | In Stock |
|
| 25MG | 277 | In Stock |
|
| 50MG | 422 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namem-PEG7-4-nitrophenyl carbonate
-
NoteResearch use only, not for human use.
-
Brief Descriptionm-PEG7-4-nitrophenyl carbonate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Descriptionm-PEG7-4-nitrophenyl carbonate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Synonyms——
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPEGs;Alkyl/ether
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number678150-56-6
-
Formula Weight461.5
-
Molecular FormulaC20H31NO11
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCOCCOCCOCCOCCOCCOCCOC(OC1=CC=C([N+]([O-])=O)C=C1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
-
NH2-PEG6-Boc
NH2-PEG6-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. NH2-PEG6-Boc is also a non-cleavable 6 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
-
BSJ-03-123
BSJ-03-123 is a potent, CDK6-selective small-molecule degrader (PROTAC) that uniquely enables rapid pharmacological interrogation of CDK6-dependent functions.
-
TL13-112
TL13-112 is a novel Anaplastic Lymphoma Kinase (ALK)-PROTAC developed through conjugation of LDK378 and the cereblon ligand pomalidomide.
